questionsmedicales.fr
Maladies de l'appareil respiratoire
Maladies pulmonaires
Poumon hyperclair
Poumon hyperclair : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Radiographie
Scanner
Poumon hyperclair
Tomodensitométrie
Tests fonctionnels respiratoires
Densité pulmonaire
Radiologie
Hyperinflation
Physiologique
Anamnèse
Maladies respiratoires
Symptômes
5
Dyspnée
Toux
Douleurs thoraciques
Douleurs thoraciques
Maladies sous-jacentes
Enfants
Symptômes respiratoires
Toux
Causes sous-jacentes
Asymptomatique
Hyperinflation
Prévention
5
Prévention
Tabagisme
Polluants environnementaux
Vaccination
Grippe
Pneumocoque
Surveillance
Tests de fonction pulmonaire
Exercices respiratoires
Capacité pulmonaire
Habitudes de vie
Alimentation équilibrée
Traitements
5
Traitement
Bronchodilatateurs
Asthme
Antibiotiques
Infection bactérienne
Corticostéroïdes
Inflammation
Thérapies respiratoires
Bronchodilatateurs
Complications
5
Complications
Pneumothorax
Insuffisance respiratoire
Infections pulmonaires
Hyperinflation
Risques à long terme
Fonction pulmonaire
Facteurs de risque
5
Facteurs de risque
Tabagisme
Polluants
Asthme
BPCO
Maladies pulmonaires
Mode de vie
Sédentarité
Alimentation
Allergies
Problèmes pulmonaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Poumon hyperclair : Questions médicales les plus fréquentes",
"headline": "Poumon hyperclair : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Poumon hyperclair : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-19",
"dateModified": "2025-02-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Poumon hyperclair"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies pulmonaires",
"url": "https://questionsmedicales.fr/mesh/D008171",
"about": {
"@type": "MedicalCondition",
"name": "Maladies pulmonaires",
"code": {
"@type": "MedicalCode",
"code": "D008171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Poumon hyperclair",
"alternateName": "Lung, Hyperlucent",
"code": {
"@type": "MedicalCode",
"code": "D019568",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hiromichi Niikawa",
"url": "https://questionsmedicales.fr/author/Hiromichi%20Niikawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan."
}
},
{
"@type": "Person",
"name": "Kenneth R McCurry",
"url": "https://questionsmedicales.fr/author/Kenneth%20R%20McCurry",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA."
}
},
{
"@type": "Person",
"name": "Joshua M Diamond",
"url": "https://questionsmedicales.fr/author/Joshua%20M%20Diamond",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Hisashi Oishi",
"url": "https://questionsmedicales.fr/author/Hisashi%20Oishi",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp."
}
},
{
"@type": "Person",
"name": "Takashi Hirama",
"url": "https://questionsmedicales.fr/author/Takashi%20Hirama",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Osteosarcoma.",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36481668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41572-022-00409-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advances in Osteosarcoma.",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37329384",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11914-023-00803-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36928868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cncr.34744"
}
},
{
"@type": "ScholarlyArticle",
"name": "Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36842425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgo.2023.101445"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.",
"datePublished": "2022-10-13",
"url": "https://questionsmedicales.fr/article/36311748",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.871076"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies pulmonaires",
"item": "https://questionsmedicales.fr/mesh/D008171"
},
{
"@type": "ListItem",
"position": 4,
"name": "Poumon hyperclair",
"item": "https://questionsmedicales.fr/mesh/D019568"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Poumon hyperclair - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Poumon hyperclair",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Poumon hyperclair",
"description": "Comment diagnostiquer un poumon hyperclair ?\nQuels examens complémentaires sont utiles ?\nQuels signes radiologiques indiquent un poumon hyperclair ?\nLe poumon hyperclair est-il toujours pathologique ?\nQuel rôle joue l'anamnèse dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Osteosarcoma#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Poumon hyperclair",
"description": "Quels symptômes sont associés au poumon hyperclair ?\nLe poumon hyperclair provoque-t-il des douleurs ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nComment la toux se manifeste-t-elle ?\nLe poumon hyperclair est-il asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Osteosarcoma#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Poumon hyperclair",
"description": "Comment prévenir le poumon hyperclair ?\nY a-t-il des vaccinations recommandées ?\nComment surveiller la santé pulmonaire ?\nLes exercices respiratoires aident-ils ?\nQuelles habitudes de vie adopter ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Osteosarcoma#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Poumon hyperclair",
"description": "Quel traitement pour un poumon hyperclair ?\nLes antibiotiques sont-ils nécessaires ?\nQuand envisager une intervention chirurgicale ?\nLes corticostéroïdes sont-ils efficaces ?\nComment gérer les symptômes respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Osteosarcoma#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Poumon hyperclair",
"description": "Quelles complications peuvent survenir ?\nLe poumon hyperclair peut-il entraîner des infections ?\nComment gérer les complications ?\nLe poumon hyperclair est-il réversible ?\nQuels sont les risques à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Osteosarcoma#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Poumon hyperclair",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes maladies pulmonaires prédisposent-elles ?\nLe mode de vie joue-t-il un rôle ?\nLes allergies sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Osteosarcoma#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un poumon hyperclair ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par radiographie thoracique et éventuellement par scanner."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests fonctionnels respiratoires et une tomodensitométrie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes radiologiques indiquent un poumon hyperclair ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diminution de la densité pulmonaire et une augmentation de la transparence sont observées."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il toujours pathologique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il peut être physiologique chez les jeunes enfants ou en cas d'hyperinflation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'anamnèse dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anamnèse aide à identifier des antécédents de maladies respiratoires ou d'exposition."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés au poumon hyperclair ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure une dyspnée, une toux ou des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas directement, mais des douleurs peuvent survenir en raison de maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes respiratoires aigus ou chroniques."
}
},
{
"@type": "Question",
"name": "Comment la toux se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La toux peut être sèche ou productive, selon la cause sous-jacente du poumon hyperclair."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être asymptomatique, surtout dans les cas d'hyperinflation bénigne."
}
},
{
"@type": "Question",
"name": "Comment prévenir le poumon hyperclair ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et les polluants environnementaux peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre la grippe et le pneumocoque est conseillée."
}
},
{
"@type": "Question",
"name": "Comment surveiller la santé pulmonaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction pulmonaire sont recommandés."
}
},
{
"@type": "Question",
"name": "Les exercices respiratoires aident-ils ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer la capacité pulmonaire et la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie adopter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée et faire de l'exercice régulièrement est bénéfique."
}
},
{
"@type": "Question",
"name": "Quel traitement pour un poumon hyperclair ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des bronchodilatateurs pour l'asthme."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont nécessaires que si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de complications graves comme un pneumothorax."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés pour réduire l'inflammation dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes respiratoires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bronchodilatateurs et des thérapies respiratoires peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le pneumothorax ou l'insuffisance respiratoire peuvent se produire."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair peut-il entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperinflation peut prédisposer à des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion dépend de la complication, nécessitant parfois une hospitalisation."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il réversible ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la cause; certaines conditions peuvent être réversibles avec un traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent une détérioration de la fonction pulmonaire et des complications chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à des polluants et des antécédents familiaux de maladies respiratoires."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires prédisposent-elles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de poumon hyperclair."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les allergies sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines allergies respiratoires peuvent contribuer à des problèmes pulmonaires, y compris l'hyperclarté."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/02/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
3 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. daink@kuhp.kyoto-u.ac.jp.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Cardiothoracic Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, University of Florida, Gainesville, Florida, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, University of Florida Health, Gainesville, Florida, USA.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Hospital Universitario Puerta del Mar, Cádiz, España. jj_perezguerrero@hotmail.com.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Hospital Universitario Puerta del Mar, Cádiz, España.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas Health - McGovern Medical School, Houston, TX.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Lenox Hill Hospital, New York, NY.
Publications dans "Poumon hyperclair" :
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in males. The key pathophysiolog...
This article gives a brief overview of the most recent developments in osteosarcoma treatment, including targeting of signaling pathways, immune checkpoint inhibitors, drug delivery strategies as sing...
Osteosarcoma is one of the most common primary malignant bone tumors in children and young adults, with a high risk of bone and lung metastases and a 5-year survival rate around 70% in the absence of ...
Primary rib osteosarcoma has not been investigated extensively, and clinical characteristics and optimal therapeutic strategies have not been defined. The authors used the database of the Cooperative ...
The COSS database was searched for treatment-naive, high-grade osteosarcomas of the rib. Affected patients were analyzed for demographic and tumor-related factors, treatments, and outcomes....
A total of 44 patients (23 males, 21 females; median age, 23 years [range, 6-59]) were identified. Primary metastases were detected in six of 44 (14%) patients. Surgery was performed in 40 of 44 (91%)...
This large series provides evidence that patients with costal primaries are older than the average osteosarcoma patient, but appear to share the similar tumor biology and-if treated according to stand...
Osteosarcoma is typically a disease of the young, but may affect any age. Little is known about the disease in older patients beyond retirement age. We aim to describe the characteristics, treatment, ...
The database of the Cooperative Osteosarcoma Study Group (COSS) was searched for osteosarcoma patients diagnosed from 1980 to 2020 who were aged 65 years or older at diagnosis. Affected individuals we...
Fifty-five eligible patients were detected (median age 68 [range: 65-84] years; male:female = 25:30). Among these patients, 15/55 (27%) tumors were secondary malignancies, 41/55 (75%) were high-grade ...
Osteosarcomas can occur in older individuals. It is more often secondary, axially located, or extraosseous than in younger patients. However, the same treatment principles seem to apply, and selected ...
Osteosarcoma (OS) is one of the most common primary malignant tumors originating in bones. Its high malignancy typically manifests in lung metastasis leading to high mortality. Although remarkable adv...
Chondroblastoma-like osteosarcoma (CBLOS) is a rare and poorly understood variant of OS. We examined the clinicopathological, immunohistochemical and molecular features of six CBLOSs to highlight the ...
We performed histone 3.3 mutation analysis by gene sequencing and/or immunohistochemistry in all cases, while whole exome sequencing (WES) was performed on two CB-like osteosarcomas and 11 conventiona...
CBLOSs were predominantly localised at acral sites and involved mainly male subjects with a mean age of 29 years. One patient who had metastases at presentation died of disease, while another patient ...
CBLOS presents a different genetic background and a less aggressive clinical behaviour in comparison with CHGOS. Search of the H3F3B K36M mutation is useful in the differential diagnosis with CB....
Primary osteosarcomas are rarely seen in areas other than bone, although they can occur in sites such as the thigh, anal region, hand, etc. We present a case of primary extraskeletal osteosarcoma of t...
Osteosarcoma (OS) is the most prevalent and fatal type of bone tumor. It is characterized by great heterogeneity of genomic aberrations, mutated genes, and cell types contribution, making therapy and ...
Osteosarcoma has become the most common bone malignancy in adolescents. Although the clinical treatment of osteosarcoma has advanced considerably in recent years, the 5-year survival rate has not impr...
We selected prognostic genes that are closely associated with osteosarcoma clinical features by obtaining osteosarcoma patient information from the GTEx and TARGET databases, and then we developed a r...
In conclusion, we validated that the prognostic factor FKBP11 is closely associated with osteosarcoma. Additionally, we identified a novel mechanism by which FKBP11 ameliorates the malignant propertie...
There is no clear consensus guideline that specifies the optimum course of treatment for adult head and neck osteosarcoma (HNO) because of its rarity. The review's goal is to examine the most recent r...
Due to overlapping symptoms with various benign disorders of the lower jaw and midface bone, these patients present with a noticeable delay. The greatest results for these malignancies can be achieved...
Multimodality treatments seem to yield better results for advanced HNO with adverse features and incomplete resections....